Bioblast Pharma Mutual Funds

Health Care & Life Sciences » Biotechnology | Bioblast Pharma Ltd.

Bioblast Pharma Ltd. | Mutual Funds

Name

Shares Held

% Shares Out

Change In Shares

% of Assets

As of Date

Yelin Lapidot Menayatit

25,921

0.78%

0.01%

04/30/2018

Yelin Lapidot Gmisha Memukedet

10,156

0.3%

0.01%

06/28/2018

Yelin Lapidot Yeter

10,000

0.3%

0.01%

04/30/2018

Yelin Lapidot Memukeder Didivend

4,933

0.15%

04/30/2018

4,000

0.12%

0.01%

04/30/2018

3,130

0.09%

06/28/2018

300

0.01%

06/28/2018

View Profile

Address	37 Dereh Menachem Begin Street Tel Aviv TA 6522042 Israel
Employees	-
Website	http://www.bioblastpharma.com
Updated	09/14/2018
Bioblast Pharma Ltd. operates as a clinical development-stage biopharmaceutical company. It focuses on the identification, licensing, acquisition, development and commercialization of drugs for rare and ultra-rare genetic diseases. The company also focuses on diseases with severe and debilitating manifestations, where the unmet medical need is clear, the biological mechanism of action is understood, and for which there is no satisfactory treatment.